PHH

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.78
Percentage change 1.96	%

Held by: PGJ

Scroll to Statements

Index	-	P/E	700.86	EPS (ttm)	0.06	Insider Own	81.71%	Shs Outstand	25.00M	Perf Week	20.49%
Market Cap	1.07B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.82M	Perf Month	195.99%
Enterprise Value	1.07B	PEG	-	EPS next Q	-	Inst Own	0.19%	Short Float	1.22%	Perf Quarter	206.26%
Income	0.48M	P/S	449.62	EPS this Y	-	Inst Trans	-35.87%	Short Ratio	0.13	Perf Half Y	736.70%
Sales	2.38M	P/B	673.64	EPS next Y	-	ROA	17.89%	Short Interest	0.06M	Perf YTD	545.15%
Book/sh	0.06	P/C	1945.63	EPS next 5Y	-	ROE	38.00%	52W High	39.98 1.50%	Perf Year	-
Cash/sh	0.02	P/FCF	1229.99	EPS past 3/5Y	-65.38% -	ROIC	30.70%	52W Low	3.70 996.76%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	1304.41	Sales past 3/5Y	11.40% -	Gross Margin	91.80%	Volatility	4.76% 9.65%	Perf 5Y	-
Dividend TTM	-	EV/Sales	449.42	EPS Y/Y TTM	-91.85%	Oper. Margin	33.32%	ATR (14)	2.00	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.09	Sales Y/Y TTM	-3.14%	Profit Margin	20.09%	RSI (14)	92.89	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.15	EPS Q/Q	-94.14%	SMA20	51.05%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.05	Sales Q/Q	40.59%	SMA50	111.03%	Rel Volume	1.88	Prev Close	39.80
Employees	31	LT Debt/Eq	0.03	Earnings	-	SMA200	228.35%	Avg Volume	468.30K	Price	40.58
IPO	Dec 27, 2024	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	880,624	Change	1.96%

Apr-30-25 06:21AM	Why Park Ha Biological Technology Co., Ltd. (PHH) is Surging in 2025 (Insider Monkey)
Mar-31-25 05:03AM	Park Ha Biological Technology: Growth Potential And Profitability Concerns (Seeking Alpha)
Mar-25-25 09:24AM	Why Park Ha Biological Technology Co Ltd (PHH) Is Surging In 2025? (InsiderMonkey) -11.83%
Mar-09-25 06:02PM	Why Park Ha Biological Technology Co., Ltd. (PHH) Soared Last Week (Insider Monkey)
Jan-06-25 08:00AM	D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering (GlobeNewswire) +7.05%
05:30PM	Loading…
Dec-30-24 05:30PM	Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering (GlobeNewswire) +19.16% +29.69%
Dec-26-24 09:46PM	Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering (GlobeNewswire)

Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. It operates through the Product Sales and Franchise Service segments. The company was founded by Xiao Qiu Zhang on October 11, 2022 and is headquartered in Wuxi, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Park Ha Biological Technology Co Ltd

Upgrade your FINVIZ experience